Eledon Pharma Analyst Ratings
H.C. Wainwright Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating, Maintains Target Price $16
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Eledon Pharmaceuticals (ELDN)
Eledon Pharmaceuticals, Inc.'s (NASDAQ:ELDN) Market Cap Dropped US$57m Last Week; Individual Investors Who Hold 57% Were Hit as Were Institutions
Eledon Pharmaceuticals Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 EPS Results.
Ladenburg Thalmann Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating, Cuts Target Price to $20.5